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Abstract. There is a dearth of technology and methods to aid process characterization, 
control and scale-up of complex culture platforms that provide niche micro-environments for 
some stem cell-based products. We have demonstrated a novel use of 3d in-vivo imaging 
systems to visualize medium flow and cell distribution within a complex culture platform 
(hollow fiber bioreactor) to aid characterization of potential spatial heterogeneity and identify 
potential routes of bioreactor failure or sources of variability. This can then aid process 
characterization and control of such systems with a view to scale-up. Two potential sources 
of variation were observed with multiple bioreactors repeatedly imaged using two different 
imaging systems: shortcutting of medium between adjacent inlet and outlet ports with the 
potential to create medium gradients within the bioreactor, and localization of bioluminescent 
murine 4T1-luc2 cells upon inoculation with the potential to create variable seeding densities 
at different points within the cell growth chamber. The ability of the imaging technique to 
identify these key operational bioreactor characteristics demonstrates an emerging technique 
in troubleshooting and engineering optimization of bioreactor performance.  
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Stem cell-based products always incorporate some heterogeneity due to variability in 
biological input materials, different micro-environments in the bioprocess and cell sensitivity 
to extrinsic factors. Improving the understanding, characterization and control of a bioprocess, 
is essential in ensuring process reproducibility and product quality
1-4
. In-process 
measurements aid process understanding and control, and one of the most commonly used 
methods of in-process measurement is cell number and cell viability determination, but many 
tests are invasive and subjective
1, 5
. There is a requirement for improved process control 
equipment and techniques, and the use of quantitative non-invasive and non-destructive 
automated imaging techniques are expected to become more prevalent for on-line 
monitoring
6
. However current techniques are primarily suited to 2-dimensional adherent cell 
culture formats, and for many applications 3d culture is preferable for scalable manufacture
7
. 
Although many 3d culture systems have on-line monitoring and culture maintenance 
capabilities, and traditional 3d stirred tank production technology is known to perform and be 
readily scalable for suspension cultures
2, 8, 9
, more complex 3d platforms are required for 
some cell-based bioprocesses in order to provide a more appropriate micro-environment
9, 10
. 
For example, perfused hollow fiber bioreactors have been used for primary human 
hepatocytes
11
 and hematopoietic progenitor cells
12
, where the stem cell niche is considered of 
critical importance to successful expansion, differentiation and maturation. An advantage of 
these more complex perfused bioreactors is a higher surface area to volume ratio leading to 
potentially higher product yields, improved homogeneity relative to fed-batch or static 
methods, and reduced waste accumulation. Yet the disadvantages associated with such 
systems are variable harvest yield, increased risk of heterogeneous culture conditions or cell 
distribution with complex internal structure/flow (primarily rigid systems), increased risk of 
problematic cell dissociation, and unknown or negative effects of continuous removal of 
paracrine factors
13, 6, 10
. There is a requirement to evaluate methods of in-process bioreactor 
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monitoring and bioreactor failure modes in such systems that are inherently difficult to 
characterize in order to assess what drives variability in such systems. Here we demonstrate 
the proof of principle that 3d in-vivo imaging systems can be utilized to image medium and 
bio- distribution in a hollow fiber cell culture bioreactor to aid characterization of potential 
spatial heterogeneity and sources of variability.  
Two potential sources of heterogeneity were investigated: media distribution and cell 
seed distribution within the bioreactor. Equipment for in vivo bio-monitoring were considered 
as good candidates to allow monitoring of flow patterns and cell distribution in the bioreactor. 
The laboratory scale bioreactor has an 8 mL cell chamber whereas the clinical scale 
bioreactor has an 800 mL cell chamber (Stemcell Systems GmbH, Berlin, Germany). The cell 
chamber comprises layers of counter-currently perfused medium capillaries with integrated 
gas capillaries. Cells are cultured outside the fibers in the extra-capillary space and medium / 
gas is circulated through semi-permeable fibers through the intra-capillary space. The internal 
structure of the bioreactor, the perfusion set up, perfusion and inoculation conditions have 
been described in detail elsewhere
13
. Two imaging systems were used; the Pearl Impulse 
system (LI-COR Biosciences, Cambridge, UK) and the Ivis Kinetic system (Caliper Life 
Sciences, Cheshire, UK). As the Pearl Impulse system does not have the chamber capacity to 
analyze an 800 mL bioreactor, a further high capacity system, the Ivis Kinetic, was also 
investigated as this has the potential for downstream use with a scaled bioreactor. 
Medium distribution. The Pearl Impulse Imager was shown to be capable of detecting 
artificially induced fluorescence and flow patterns of fluorescent liquid (IR Dye
®
 800CW 
probe, LI-COR Biosciences) within the bioreactor and these signals were distinguishable 
from background auto-fluorescence of the plastic. Fluorescent dye-spiked buffer was 
perfused under counter-current flow through the bioreactor to capture video of flow 
characteristics. Figure 1 shows a cross-section of still images from a representative video 
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sequence. It identifies shortcutting of medium flow from the inlet port to the adjacent exit 
port, rather than crossing the bioreactor to the appropriate opposite exit port for each medium 
capillary network. The medium shortcutting was observed at the higher flow 20 mL/min 
medium recirculation rate
13
 and could potentially decrease the homogeneity of the bioreactor 
and linearity of process scalability. As perfusion continued for a few minutes medium was 
subsequently capable of circulating to all parts of the chamber at this flow rate (as shown in 
the latter images from the video sequence). Prior to using the Ivis Kinetic imager, spectral 
analysis of the hollow fiber bioreactor was conducted using an Ivis Spectrum system (Caliper 
Life Sciences) to image the bioreactor with a large number of filters (green fluorescent 
protein, GFP, range to near-infrared, NIR, range) to identify excitation/emission 
combinations for the lowest background noise signal. The 710/780 excitation/emission filter 
combination provided the lowest background fluorescence, indicating the Xenolight CF750 
dye (Caliper Life Sciences) or similar alternative and the 700 nanometer (nm) filter wheel in 
the Ivis Kinetic would achieve the best fluorescent imaging data (Figure 2A). Additionally, 
Figure 2B, with blocked excitation, showed that the bioreactor had no detectable 
phosphorescence suggesting the possibility of tracking a bioluminescent cell population. The 
shortcutting of fluorescent dye-spiked media between adjacent medium in-flow and out-flow 
ports observed previously was also observed when bioreactors were imaged using the Ivis 
Kinetic under identical counter-current medium perfusion conditions (Figure 2C shows a still 
image from a representative video sequence). The effect of medium short-cutting was 
observed in multiple bioreactors with two different imaging systems suggesting that this 
could be a source of potential process variation. Additionally, as medium short-cutting was 
observed at the higher circulation flow rate, there is potential for differences or gradients to 
arise at lower flow rates such as the 4 mL/min cell feeding rate
13
. 
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Cell Seeding distribution. A mock cell seeding exercise using the Pearl Impulse Imager and 
inoculating fluorescent dye-spiked buffer (IR Dye
®
 800CW, 800 nm fluorescence channel) 
into the cell inoculation port appeared to show uneven dye distribution after seeding, thereby 
suggesting the potential for non-homogenous cell density within the cell chamber as another 
possible candidate for introducing process variability. To further investigate cell distribution 
after seeding into the cell chamber of the bioreactor, a population of bioluminescent murine 
cells (4T1-luc2, Caliper Life Sciences) were inoculated into the bioreactor under conditions 
described previously
13
. The Ivis Kinetic imager was able to detect the bioluminescent 
population within the hollow fiber bioreactor, and showed that the cells appeared to localize 
in the center of the cell chamber (Figure 3), suggesting that distribution in the compartment 
may not be homogenous at inoculation.  
Shortcutting of medium between adjacent inlet and outlet ports has the potential to 
create medium gradients, and heterogeneous distribution of cells upon inoculation has the 
potential to create variable seeding densities within the bioreactor. Such sources of variation 
could cause considerable process performance heterogeneity problems with scale-up. Small 
scale bioreactor systems using low cell densities tend to function well as there is an excess of 
nutrients available. However, as systems are scaled and higher cell densities achieved, early 
identification of heterogeneity issues can be critical as cell and medium gradients may result 
in some cells being starved of both nutrients and oxygen with others being overfed. Variation 
in harvest cell yield from the bioreactors has been observed previously
13
 and the ability of the 
imaging technique to identify these key operational bioreactor characteristics that may 
contribute to such variation demonstrates a powerful emerging role in troubleshooting and 
engineering optimization of bioreactor performance. Defining procedures to maximize cell 
seeding homogeneity (e.g. optimized liquid chasing or bioreactor rotation procedures) could 
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improve this situation and be further explored with imaging as an initial output, with 
subsequent population distribution tracking, cell yield, viability and characterization 
measurements. Imaging could also be used as an initial output alongside cell yield and 
viability to further inform modeling experiments and explore the effect of optimizing medium 
perfusion rates and distribution on cell expansion or other bioreactor phenomena such as 
Starling flows (secondary flow in the cell chamber driven by elevated medium recirculation 
levels in the capillaries)
14, 15
. Technique limitations would also need to be further defined, for 
example the qualitative nature of the 2d heat-map data may be addressed by region of interest 
(ROI) definition to attain quantitative fluorescence and phosphorescence data from the 
Imaging system software. As well as further definition of the potential for obtaining complete 
3d images and quantitative data. More work is also required to define the achievable 
resolution of the technique, for example whether single cell imaging is possible.  
The technique may also be useful for other hollow fiber technology applications. For 
example, Pinzon et al. (2013) recently demonstrated a microbe-based bio-surfactant 
production process using hollow fiber technology under denitrifying conditions in order to 
eliminate the common oxygen transfer limitations and foaming difficulties that are inherent to 
the current aerobic process
16
. Cell entrapment within the extra-capillary space offered the 
advantage of easy soluble product recovery from perfused medium and the authors suggest 
bioreactor scale-up should be explored
16
. The imaging technique described may offer 
advantages to the scaling process to assess labeled cell distribution or tracing labeled 
feedstock compounds for localization or limitation. Additionally as continuous product 
harvesting via multivalent cation addition and extraction is an attractive concept
16
 the 
technique could be used to assess residues alongside cell tracking and measures of cell 
viability. Another area where the technique may offer unique advantages is for those 
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processes that require further cell immobilization, for example alginate immobilization to 
promote stem cell differentiation or increased levels of insulin production in pancreatic / 
islet-like cell clusters
17
. A novel bioprocess for alginate immobilization of mammalian cells 
within a hollow-fiber bioreactor was recently demonstrated be Hoesli et al. (2009) and key 
processing issues included the obstruction of medium flow due to alginate crossing the 
membranes from the extra-capillary space into the intra-capillary space as well as cell 
recovery from the extra-capillary space
17
. The method used to assess effective alginate 
gelling during method development was visual inspection of sawed hollow fiber cartridges
17
. 
The imaging technique described would eliminate the need for destruction of hollow fiber 
cartridges and could be used to trace labeled alginate for effective gelling or labeled medium 
flows through alginate bioreactors. Additionally, labeled cells could be used for method 
development of cell recovery or to trace effective removal and residues of temperature 
sensitive alginate gel for more effective recovery.  
The work described demonstrates that as a proof-of-principle medium and bio-
distribution imaging in complex hollow fiber cell culture bioreactors is possible using 3d in-
vivo imaging techniques. Additionally, imaging of medium distribution and bioluminescent 
cell populations in this manner could be particularly useful for early detection of 
heterogeneity within complex 3d cell culture platforms and aid engineering of operational 
parameters to improve process performance and control prior to scale-up.  
Materials and Methods. The Pearl Impulse system is a fluorescent imaging platform with 
laser excitation and near-infrared (NIR) fluorescence detection (see 
http://www.licor.com/bio/products/imaging_systems/pearl/pearl_imager.jsp). The Ivis 
Kinetic system is a filter-based platform for fluorescence (green fluorescent protein, GFP-
NIR range) or bio-luminescence (see 
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www.perkinelmer.com/SG/Catalog/Category/ID/IVIS%20Series). The hollow fiber 
bioreactors were provided courtesy of Celgene Cellular Therapeutics (New Jersey, USA); 
they are produced by Stemcell Systems GmbH (Berlin, Germany) 
13, 18
. Each laboratory scale 
bioreactor consists of an 8 mL cell compartment and multiple layers of three independent 
capillary networks that are interwoven and provide counter-current medium perfusion and 
integrated gas supply. The internal structure of the bioreactor, the perfusion set up, perfusion 
and inoculation conditions have been described in detail elsewhere
13
. Bioreactors were 
perfused at the medium recirculation rate of 20 mL/min
13
. Fluorescent imaging of liquid flow 
patterns with the Pearl Impulse imager (calibrated to manufacturer’s standards) was 
performed using the IR Dye
®
 800CW probe (1µg/mL in PBS, LI-COR Biosciences), 800 
nanometers (nm) fluorescence channel detection and 0.5 s image acquisition. Spectral 
analysis of the bioreactor was performed using an Ivis Spectrum imaging platform (Caliper 
Life Sciences, calibrated to manufacturer’s standards) to image the bioreactor rapidly with 
GFP range to NIR range filters for background fluorescence as well as phosphorescence. 
Fluorescent imaging of liquid flow patterns with the Ivis Kinetic imager (calibrated to 
manufacturer’s standards) was performed using the Xenolight CF750 dye (1 mM in dH2O), 
700 nm filter wheel detection and 0.5 s image acquisition. Cell localization imaging was 
performed using the luciferase expressing 4T1-luc2 Bioware Ultra murine cell line, cultured 
according to manufacturer’s conditions in RPMI-1640 medium (ATCC, #30-2001) 
supplemented with 10% FBS (Fisher Scientific, Loughborough, UK). 4T1-luc2 cells were 
prepared to 5×10
4 
/mL density and exposed to Xenolight D-luciferin potassium salt substrate 
(150 µg/mL in RPMI-1640) at 37ºC for 5 min. Cells were inoculated into the 8 mL bioreactor 
cell chamber port at a density of 8×10
5 
/mL (6.4×10
6
 cells in total), as described previously
13
, 
for subsequent imaging (37 ºC imaging chamber). All reagents, cell lines and substrates for 
Ivis Kinetic Imaging were provided courtesy of Caliper Life Sciences. Imaging was 
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performed in duplicate (minimum) with duplicate (minimum) bioreactors unless otherwise 
stated, a total of 6 bioreactors were used in this study.  
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Figure Captions 
Figure 1. Image A shows the hollow fiber bioreactor structure: (Port 1) gas outlet, (2) 
medium outlet, (3) counter-current flow medium inlet, (4) cell inoculation port, (5) gas inlet, 
(6) medium inlet and (7) medium outlet. Inset: illustrated hollow fiber layers of gassing 
(grey), medium (pink), and counter-current flow medium (blue) fibers. Image B shows a 
cross-section of still images from a representative video sequence of counter-current flow 
medium perfusion. The images were taken using the Pearl Impulse Imaging system, IR Dye
®
 
800CW and the 800 nm fluorescence channel. Numbered bioreactor ports (1-7) are clearly 
visible at the beginning of the sequence (B1) and the bioreactor remains in the same 
orientation throughout imaging. White arrows show counter-current medium perfusion (B1) 
and black arrows show medium short-cutting to adjacent rather than opposite exit ports (B4).  
1 
4 
3 2 
6 5 
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Figure 2. Spectral analysis of the hollow fiber bioreactor using an Ivis Spectrum imaging 
system and GFP to NIR range filters. Bioreactor ports are numbered from 1-7 (in white) to 
show orientation (black port numbers painted on the bioreactor casing have been obscured by 
signal in some places). Image A shows the minimal background noise signal can be achieved 
with the 710/780 excitation/emission filter combination. Image B shows blocked excitation 
and no detectable phosphorescence for bioluminescence experimentation. Image C is taken 
from a video sequence using the Ivis Kinetic Imaging system (710/780 excitation/emission 
filter combination) and shows Xenolight CF750 fluorescent dye-spiked counter-current 
medium perfusion (white arrows) and medium short cutting to adjacent rather than opposite 
exit ports (black arrows).  
Figure 3. Ivis Kinetic Imager photographs of the bioreactor from two angles after inoculation 
of luciferase expressing 4T1-luc2 Bioware Ultra murine cells (6.4×10
6
 cells at 8×10
5 
/mL 
density) into the cell chamber to assess inoculated cell distribution. Bioreactor ports are 
numbered from 1-7 (in white) to show orientation (black port numbers painted on the 
bioreactor casing have been obscured by signal in some places). Port 4 is used for cell 
inoculation into the cell chamber. 
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Image A shows the hollow fiber bioreactor structure: (Port 1) gas outlet, (2) medium outlet, (3) counter-
current flow medium inlet, (4) cell inoculation port, (5) gas inlet, (6) medium inlet and (7) medium outlet. 
Inset: illustrated hollow fiber layers of gassing (grey), medium (pink), and counter-current flow medium 
(blue) fibers. Image B shows a cross-section of still images from a representative video sequence of 
counter-current flow medium perfusion. The images were taken using the Pearl Impulse Imaging system, IR 
Dye® 800CW and the 800 nm fluorescence channel. Numbered bioreactor ports (1-7) are clearly visible at 
the beginning of the sequence (B1) and the bioreactor remains in the same orientation throughout imaging. 
White arrows show counter-current medium perfusion (B1) and black arrows show medium short-cutting to 
adjacent rather than opposite exit ports (B4).  
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Spectral analysis of the hollow fiber bioreactor using an Ivis Spectrum imaging system and GFP to NIR range 
filters. Bioreactor ports are numbered from 1-7 (in white) to show orientation (black port numbers painted 
on the bioreactor casing have been obscured by signal in some places). Image A shows the minimal 
background noise signal can be achieved with the 710/780 excitation/emission filter combination. Image B 
shows blocked excitation and no detectable phosphorescence for bioluminescence experimentation. Image C 
is taken from a video sequence using the Ivis Kinetic Imaging system (710/780 excitation/emission filter 
combination) and shows Xenolight CF750 fluorescent dye-spiked counter-current medium perfusion (white 
arrows) and medium short cutting to adjacent rather than opposite exit ports (black arrows).  
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Ivis Kinetic Imager photographs of the bioreactor from two angles after inoculation of luciferase expressing 
4T1-luc2 Bioware Ultra murine cells (6.4×106 cells at 8×105 /mL density) into the cell chamber to assess 
inoculated cell distribution. Bioreactor ports are numbered from 1-7 (in white) to show orientation (black 
port numbers painted on the bioreactor casing have been obscured by signal in some places). Port 4 is used 
for cell inoculation into the cell chamber.  
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